Method Pharmaceuticals, LLC Sustainability Profile
Method Pharmaceuticals, LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of innovative drug delivery systems. Founded in 2015, the company has rapidly established itself as a leader in the field, focusing on advanced formulations that enhance patient outcomes. With a strong operational presence across North America and Europe, Method Pharmaceuticals is dedicated to providing unique solutions in the areas of injectable medications and specialty pharmaceuticals. Their core products are distinguished by their commitment to quality and efficacy, utilising cutting-edge technology to meet the evolving needs of healthcare providers and patients alike. Recognised for its significant contributions to the industry, Method Pharmaceuticals continues to push the boundaries of pharmaceutical innovation, positioning itself as a trusted partner in the healthcare landscape.
DitchCarbon Score
How does Method Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Method Pharmaceuticals, LLC's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Method Pharmaceuticals, LLC's reported carbon emissions
Method Pharmaceuticals, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Method Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific emissions data or commitments, it is unclear how Method Pharmaceuticals aligns with these industry trends. As the company continues to operate, it may consider developing and disclosing its climate commitments to enhance transparency and contribute to broader environmental goals.
How Carbon Intensive is Method Pharmaceuticals, LLC's Industry?
How Carbon Intensive is Method Pharmaceuticals, LLC's Location?
Method Pharmaceuticals, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Method Pharmaceuticals, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
